CSF3 and autoimmune disease: The literature reports results from a prospective 5‐year study of 6768 peripheral blood stem cell donors who were treated with G‐CSF and 2726 bone marrow donors who were not treated with G‐CSF.13 The results of that study showed that peripheral blood stem cell donors were not at increased risk for developing an autoimmune disease when compared to bone marrow donors.